Atlas Trials

Prostate Cancer

4,470 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prostate Cancer

RecordFirmDate
IG-VMAT for Localized Prostate Cancer (NCT02934685)Beijing Hospital2016-06-01
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (NCT02968784)InSightec2016-06-01
MRI Versus PSA in Prostate Cancer Screening (NCT02799303)Sunnybrook Health Sciences Centre2016-06-01
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer (NCT02796898)Tyme, Inc2016-06-01
A Study of Definitive Therapy to Treat Prostate Cancer (NCT02716974)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-06-01
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy (NCT02790216)Sheba Medical Center2016-06-01
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer (NCT02608359)Johnson & Johnson Private Limited2016-05-31
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer (NCT02735252)University of California, San Francisco2016-05-25
MRI Guided SBRT for Localized Prostate Cancer (NCT03778112)Rush University Medical Center2016-05-23
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (NCT03703778)Chinese University of Hong Kong2016-05-22
Miami Membrane for Potency (MMEP) Trial (NCT02710422)University of Miami2016-05-17
AASUR in High Risk Prostate Cancer (NCT02772588)Memorial Sloan Kettering Cancer Center2016-05-12
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer (NCT02769962)National Cancer Institute (NCI)2016-05-09
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT02452008)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-05-03
ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy (NCT02773940)Precision Biopsy, Inc.2016-05-01
Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination (NCT02747563)Kaplan Medical Center2016-05-01
Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer (NCT02796807)Sir Mortimer B. Davis - Jewish General Hospital2016-05-01
Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP (NCT02812173)St. Antonius Hospital Gronau2016-05-01
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer (NCT02726009)Ferring Pharmaceuticals2016-05-01
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients. (NCT02969564)Valentina Garibotto2016-05-01
Phase II Laser Focal Therapy of Prostate Cancer (NCT02243033)HALO Diagnostics2016-05-01
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) (NCT02768363)Candel Therapeutics, Inc.2016-05-01
Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer (NCT02692105)British Columbia Cancer Agency2016-05-01
The BARCODE 1 Pilot Study (NCT03158922)Institute of Cancer Research, United Kingdom2016-04-29
Stereotactic Body Radiation for Prostate Oligometastases (NCT02680587)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-04-28
French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. (NCT03331068)Institut Paoli-Calmettes2016-04-26
Validation Study on the Impact of Decipher® Testing - VANDAAM Study (NCT02723734)H. Lee Moffitt Cancer Center and Research Institute2016-04-13
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer" (NCT03209492)Takeda2016-04-01
STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies (NCT02788825)Karolinska Institutet2016-04-01
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr (NCT02689271)University College, London2016-04-01
Sulphate Accumulation in Prostate (NCT02821728)Quadram Institute Bioscience2016-04-01
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) (NCT02594072)University of British Columbia2016-04-01
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study (NCT02786459)University Health Network, Toronto2016-04-01
Integrated 18F-labelled PSMA Project (NCT02691169)St. Joseph's Healthcare Hamilton2016-04-01
Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. (NCT02745587)University Hospital, Ghent2016-04-01
Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization (NCT03440554)University of California, San Diego2016-03-24
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer (NCT02526368)Ivan de Kouchkovsky, MD2016-03-22
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02737332)Sun Pharmaceutical Industries Limited2016-03-21
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (NCT02601014)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-03-15
Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer (NCT03744494)University College Hospital, Ibadan2016-03-02
Study of MR-based IGRT for Prostate Cancer (NCT02724670)University Hospital Tuebingen2016-03-01
Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) (NCT02724618)Shahid Beheshti University of Medical Sciences2016-03-01
SBRT for Oligometastatic Castration-Refractory Prostate Cancer (NCT02816983)Mayo Clinic2016-03-01
Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation? (NCT02759380)Sahlgrenska University Hospital2016-03-01
Asia Study Group of Prostate Cancer (A-CaP Study) (NCT02873013)Japan Study Group of Prostate Cancer2016-03-01
True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners (NCT02702453)University of Michigan2016-03-01
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases (NCT02758132)University of Hawaii2016-03-01
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate (NCT02822963)National Cheng-Kung University Hospital2016-03-01
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer (NCT02723526)Fudan University2016-03-01
Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate (NCT02882958)Massachusetts General Hospital2016-03-01
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy (NCT02573636)Sir Mortimer B. Davis - Jewish General Hospital2016-03-01
ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes (NCT02840617)Third Affiliated Hospital, Sun Yat-Sen University2016-03-01
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program (NCT02585362)Kantonsspital Winterthur KSW2016-03-01
Preoperative Brimonidine on IOP of Patients Undergoing RALP (NCT02818816)University Health Network, Toronto2016-02-29
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer (NCT02499497)Dana-Farber Cancer Institute2016-02-29
Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer (NCT03100981)University of Aarhus2016-02-24
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients (NCT03524391)NMP Medical Research Institute2016-02-12
Neoadjuvant J591 Treatment for Prostate Cancer (NCT02693860)Weill Medical College of Cornell University2016-02-04
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors (NCT02957357)Alliance Foundation Trials, LLC.2016-02-01
Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer (NCT02618200)Hospices Civils de Lyon2016-02-01
Robotic Surgery After Focal Ablation Therapy (NCT03011606)Queen Mary University of London2016-02-01
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (NCT02685267)Prostate Cancer Clinical Trials Consortium2016-02-01
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (NCT02397317)University of Sydney2016-02-01
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer (NCT02572284)H. Lee Moffitt Cancer Center and Research Institute2016-01-27
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate (NCT03853902)Northwestern University2016-01-26
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer (NCT02649855)National Cancer Institute (NCI)2016-01-19
SPORT High-Risk Trial Evaluating SABR in Prostate Cancer (NCT03253978)Belfast Health and Social Care Trust2016-01-18
Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study (NCT02895230)Rennes University Hospital2016-01-01
Hong Kong Prostate Cancer Study Group Database (NCT03344835)Chinese University of Hong Kong2016-01-01
Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study (NCT07608419)General University Hospital, Prague2016-01-01
PET/MRI in Patients With Suspected Prostate Cancer (NCT02659527)Medical University of Vienna2016-01-01
Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO (NCT04516707)Institut du Cancer de Montpellier - Val d'Aurelle2016-01-01
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT02821793)Institut Bergonié2016-01-01
Reducing Dexamethasone Around Docetaxel Infusion (NCT02776436)Leiden University Medical Center2016-01-01
Abiraterone-Rechallenge Study for CRPC Patients (NCT02656615)Aurelius Omlin2016-01-01
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue (NCT02594202)National Cancer Institute (NCI)2015-12-21
Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients (NCT02611882)Thomas Hope2015-12-18
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery (NCT02706561)Memorial Sloan Kettering Cancer Center2015-12-08
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer (NCT02831920)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2015-12-07
Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer (NCT02648919)University of Hawaii2015-12-01
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy (NCT02488096)Saskatchewan Health Authority - Regina Area2015-12-01
A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer (NCT02526784)Ferring Pharmaceuticals2015-12-01
Hypofractionated Radiosurgery for Localised Prostate Cancer (NCT02635256)University Hospital Schleswig-Holstein2015-12-01
Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (NCT02615067)Molecular Insight Pharmaceuticals, Inc.2015-12-01
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients (NCT02678520)University of Kansas Medical Center2015-12-01
Biparametric MRI for Detection of Significant Prostate Cancer (NCT02584179)Herlev Hospital2015-12-01
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient (NCT02588404)Sir Mortimer B. Davis - Jewish General Hospital2015-12-01
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability (NCT02663193)Janssen Scientific Affairs, LLC2015-12-01
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (NCT02489318)Aragon Pharmaceuticals, Inc.2015-11-27
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC (NCT02494921)Rahul Aggarwal2015-11-20
Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate Cancer (NCT03852017)Northwestern University2015-11-11
Body Composition and White Adipose Tissue Inflammation (NCT02713022)Memorial Sloan Kettering Cancer Center2015-11-04
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated (NCT02920229)Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2015-11-01
A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer (NCT02623647)Regina Elena Cancer Institute2015-11-01
Prostate Biopsy Access Needle & Needle Guide Feasibility Study (NCT02828839)Perineologic2015-11-01
Collaborative Network to Take Responsibility for Oral Anticancer Therapy (NCT02861209)KU Leuven2015-11-01
Salvage Radiotherapy After Radical Prostatectomy (NCT02597725)University of Aarhus2015-11-01
Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy (NCT03982706)Rabin Medical Center2015-10-28
11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. (NCT06179706)IRCCS San Raffaele2015-10-27
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (NCT03127631)McMaster University2015-10-21
← Previous Next →

Track Prostate Cancer automatically

Every clearance here is in the API, with alerts when new ones post.